申请人:MethylGene Inc.
公开号:EP2966078A2
公开(公告)日:2016-01-13
This invention relates to five specific N-hydroxybenzamide compounds for the inhibition of histone deacetylase: N-hydroxy-4-(5-(p-tolyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide; N-hydroxy-4-(5-(3-methoxyphenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide; N-hydroxy-4-(5-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide; 4-(benzo[b]thieno[2,3-f][1,4]oxazepin-10-yl)-N-hydroxybenzamide; and 4-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-hydroxybenzamide.
本发明涉及五种特定的 N-羟基苯甲酰胺化合物,用于抑制组蛋白去乙酰化酶:N-羟基-4-(5-(对甲苯基)-2,5-二氮杂双环[2.2.1]庚烷-2-基)苯甲酰胺;N-羟基-4-(5-(3-甲氧基苯基)-2,5-二氮杂双环[2.2.1]庚烷-2-基)苯甲酰胺;N-羟基-4-(5-(4-(三氟甲基)吡啶-2-基)-2,5-二氮杂双环[2.2.1]庚烷-2-基)苯甲酰胺;4-(苯并[b]噻吩并[2,3-f][1,4]氧氮杂卓-10-基)-N-羟基苯甲酰胺;以及 4-(10,11-二氢-5H-二苯并[b,f]氮杂卓-5-基)-N-羟基苯甲酰胺。